# Fecal Microbiota Transplantation for the Treatment of Primary Sclerosing Cholangitis.

> **NCT02424175** · PHASE1,PHASE2 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 10 (actual)

## Conditions studied

- Sclerosing Cholangitis

## Interventions

- **BIOLOGICAL:** Fecal Microbiota Transplantation

## Key facts

- **NCT ID:** NCT02424175
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-01
- **Primary completion:** 2017-08-30
- **Final completion:** 2018-05-08
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2019-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02424175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02424175, "Fecal Microbiota Transplantation for the Treatment of Primary Sclerosing Cholangitis.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02424175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*